Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (2,145,012)	$ (1,394,941)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Amortization and depreciation expense	5,460	5,460
Increase (decrease) in cash from change in:
Accounts receivable	1,027	(3,324)
Inventory	5,100	13,037
Prepaid expenses	(45,000)	3,575
Customer deposit	100,000
Other assets		(100,000)
Accounts payable and accrued expenses	(26,898)	328,266
Deferred revenue		(18,997)
Non-cash expense stock issued	188,463	57,400
Net Cash Used In Operating Activities	(1,008,763)	(827,474)
CASH FLOWS FROM FINANCING ACTIVITIES
Net cash provided by financing activities	1,234,644	744,000
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	225,881	(83,474)
CASH AND CASH EQUIVALENTS — BEGINNING	92,437	151,189
CASH AND CASH EQUIVALENTS — ENDING	318,318	67,715
Cash Paid During the Period for:
Interest	6,733
Taxes	2,400	2,782
SUPPLEMENTAL DISCLOSURES OF NON-CASH FINANCING AND INVESTING ACTIVITIES:
Fair value of the Winter 2012 warrant extension		233,000
Officers and Board of Directors [Member]
Increase (decrease) in cash from change in:
Non-cash expense related to options issued to board of directors	253,911	41,200
Non-cash expense stock issued	141,425
Consultants [Member]
Increase (decrease) in cash from change in:
Non-cash expense stock issued	221,187	15,000
Consultant Obligations [Member]
Increase (decrease) in cash from change in:
Non-cash expense stock issued	188,463	57,400
Board of Directors [Member]
Increase (decrease) in cash from change in:
Non-cash expense stock issued	253,911	41,200
Stock [Member]
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from the sale of stock	1,014,644	633,000
Stock in Subsidiary [Member]
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from the sale of stock	220,000	111,000
Consultants [Member]
Conversion of accrued expenses to shares of our common stock:
Conversion of accrued expenses to shares of the Company's common stock	$229,257	$34,530
Board of Directors [Member]
Conversion of accrued expenses to shares of our common stock:
Conversion of accrued expenses to shares of the Company's common stock	$166,607
Warrant [Member]
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Non-cash expense		233,000
Common Stock [Member]
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Non-cash expense	$ 291,574